# Adjunctive Fludrocortisone in Septic Shock

> **NCT07451886** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Chinese University of Hong Kong** · enrollment: 32 (estimated)

## Conditions studied

- Sepsis
- Septic Shock
- Sepsis - to Reduce Mortality in the Intensive Care Unit
- Sepsis and Septic Shock
- Sepsis at Intensive Care Unit

## Interventions

- **DRUG:** Fludrocortisone 100 mcg daily
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07451886
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2028-07-31
- **Final completion:** 2028-07-31
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07451886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07451886, "Adjunctive Fludrocortisone in Septic Shock". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT07451886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*